Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $4.4 million.

  • Pulmonx's Prepaid Assets rose 274.45% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 274.45%. This contributed to the annual value of $4.5 million for FY2024, which is 564.34% up from last year.
  • According to the latest figures from Q3 2025, Pulmonx's Prepaid Assets is $4.4 million, which was up 274.45% from $3.5 million recorded in Q2 2025.
  • Pulmonx's Prepaid Assets' 5-year high stood at $5.7 million during Q3 2021, with a 5-year trough of $3.0 million in Q1 2021.
  • In the last 5 years, Pulmonx's Prepaid Assets had a median value of $4.2 million in 2023 and averaged $4.1 million.
  • In the last 5 years, Pulmonx's Prepaid Assets soared by 44580.52% in 2021 and then plummeted by 4360.42% in 2022.
  • Pulmonx's Prepaid Assets (Quarter) stood at $4.9 million in 2021, then decreased by 11.06% to $4.3 million in 2022, then fell by 2.49% to $4.2 million in 2023, then increased by 5.64% to $4.5 million in 2024, then fell by 2.1% to $4.4 million in 2025.
  • Its Prepaid Assets stands at $4.4 million for Q3 2025, versus $3.5 million for Q2 2025 and $4.2 million for Q1 2025.